Mazdutide vs Retatrutide Retatrutide, like Mazdutide, is considered a next-generation diabetes treatment with multi-agonist properties
JANUMET XR may increase the risk of hypoglycemia when combined with insulin and/or an insulin secretagogue (e.g., sulfonylurea) [see Adverse Reactions (6)]
According to Di Vincenzo et al., ketogenic dietary interventions demonstrated the strongest effect size among the various weight loss strategies assessed, likely due to their role in enhancing mitochondrial metabolism, reducing oxidative stress, and stabilizing neuronal excitability [126]
Managing Side Effects: What to Expect gastrointestinal and temporary occurring mostly during the first few weeks or after a dose increase
Many GLP-1 users are in exactly the years where these curves cross
The official starting dose won't be confirmed until approval, but 2mg is most likely based on trial data, as it balances effectiveness with tolerability